Showing results (1361-1370 of 1,391) with videos related to
Sort By:
Pageof 140
Elife|November 23, 2021
Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationMarloes Grobben, Karlijn van der Straten, Philip Jm Brouwer, et al.EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.American Journal of Human Genetics|November 5, 2019
Genome Sequencing Explores Complexity of Chromosomal Abnormalities in Recurrent MiscarriageZirui Dong, Junhao Yan, Fengping Xu, et al.The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Zheyi Li, et al.NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.Cell Reports|October 5, 2021
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domainAdam K Wheatley, Phillip Pymm, Robyn Esterbauer, et al.Nature Metabolism|November 10, 2020
c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosisJack Leslie, Marina García Macia, Saimir Luli, et al.Ebiomedicine|May 6, 2023
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineGeorgia Deliyannis, Nicholas A Gherardin, Chinn Yi Wong, et al.Ebiomedicine|November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boosterTerry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.Pageof 140